Chemomab Therapeutics Ltd. (CMMB) has 14 open-market insider trades by 7 insiders since 2021. Over the last six months insiders net sold $7K. The most active filer is Neil Harris Cohen, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| OrbiMed Israel BioFund GP Limited Partnership via Erez Chimovits | 10% Owner | — | 1 | $2.4M | 2023-01-03 |
| George Adi Mor | CEO | — | 1 | $1.7M | 2026-05-29 |
| Neil Harris Cohen | Dir | — | 6 | $259K | 2026-08-28 |
| Dale R. Pfost | CEO | — | 1 | $10K | 2022-03-14 |
| Donald Marvin | Executive VPCFO & COO | — | 2 | $7K | 2022-03-16 |
| Joel Michael Maryles | Dir | — | 2 | $6K | 2022-05-24 |
| Nissim Darvish | Dir | — | 1 | $5K | 2022-03-11 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Neil Harris Cohen | Director | Sell | $7K | 2026-08-27 |
| George Adi Mor | CEO | Buy | $20K | 2026-05-29 |
| George Adi Mor | Chief Scientific Officer | Sell | $69K | 2023-01-03 |
| OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Sell | $2.4M | 2023-01-03 |
| Neil Harris Cohen | Director | Sell | $5K | 2022-11-16 |
| George Adi Mor | CSO | Sell | $1.7M |
Companies that share insiders with CMMB, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2022-11-16 |
| Joel Michael Maryles | Director | Buy | $1K | 2022-05-24 |
| Neil Harris Cohen | Director | Buy | $6K | 2022-05-18 |
| Joel Michael Maryles | Director | Buy | $4K | 2022-03-18 |
| Donald Marvin | Executive VP & CFO & COO | Buy | $2K | 2022-03-16 |
| Dale R. Pfost | CEO | Buy | $10K | 2022-03-14 |
| Neil Harris Cohen | Director | Buy | $26K | 2022-03-14 |
| Donald Marvin | Executive VP & CFO & COO | Buy | $5K | 2022-03-14 |
| Nissim Darvish | Director | Buy | $5K | 2022-03-11 |
| Neil Harris Cohen | Director | Buy | $15K | 2021-12-06 |